CARsgen Reports Promising Allogeneic CAR-T Data at EHA
SHANGHAI, China, June 15, 2026 CARsgen Therapeutics Holdings Limited has unveiled encouraging clinical data for its investigational allogeneic CAR...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
SHANGHAI, China, June 15, 2026 CARsgen Therapeutics Holdings Limited has unveiled encouraging clinical data for its investigational allogeneic CAR...
NEW YORK and ATHENS, Greece, June 13, 2026 Kos Biotechnology Partners has announced the successful third closing of its...
FRANKFURT, Germany and GANZHOU, China, May 26, 2026 Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have announced...
INDIANAPOLIS, United States, May 26, 2026 Eli Lilly and Company has announced three major biotechnology acquisitions aimed at significantly...
